Q&A

All articles by Q&A

Cour Pharmaceuticals CEO John Puisis discusses $105M funding round
Cour Pharmaceuticals CEO John Puisis discusses $105M funding round
Jack O'Brien
February 16, 2024
2:10 pm

Puisis recently spoke with MM+M about the funding raise, the condition of the autoimmune treatment space and the potential of Chicago’s ascendant biotech scene.

CG Life CEO David Ormesher on science-backed rebranding push, genAI’s future
CG Life CEO David Ormesher on science-backed rebranding push, genAI’s future
Jack O'Brien
January 29, 2024
12:35 pm

David Ormesher, the medical marketing veteran, shares his vision for growth — backed by science — at CG Life.

Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Jack O'Brien
December 19, 2023
10:39 am

MM+M caught up with Kakkar to discuss Tome’s funding effort, the company’s efforts to build upon the progress that’s already been made with CRISPR/Cas9 technology and why the Boston biotech scene has such momentum at its back.

Q&A: Botanical Solutions’ Gaston Salinas champions pharma sustainability
Q&A: Botanical Solutions’ Gaston Salinas champions pharma sustainability
Lecia Bushak
November 27, 2023
11:26 am

Latin America-based Botanical Solutions is banking on its platform that sustainably produces QS-21, a compound from the Quillaja saponaria tree that’s used in vaccine adjuvants.

Q&A: TikTok doc Austin Chiang on crafting the perfect patient message
Q&A: TikTok doc Austin Chiang on crafting the perfect patient message
Lecia Bushak
October 17, 2023
9:30 am

MM+M spoke with TikTok physician influencer Austin Chiang at the HLTH 2023 conference in Las Vegas, where he offered some advice for physician influencers.

Q&A: National Psoriasis Foundation CEO on the science of chronic skin disease
Q&A: National Psoriasis Foundation CEO on the science of chronic skin disease
Jack O'Brien
August 16, 2023
1:02 pm

Leah Howard, JD spoke with MM+M about the value of having vocal patient advocates challenging the stigmas associated with psoriasis.

9 questions for AbbVie’s Ilke Limoncu
9 questions for AbbVie’s Ilke Limoncu
Eric Berger
November 4, 2022
11:00 am

The biopharmaceutical company’s director of public affairs talks about opening a state-of-the-art Bay Area R&D facility.

Q&A: Novo Nordisk’s Keith Middleton on its latest DE&I efforts
Q&A: Novo Nordisk’s Keith Middleton on its latest DE&I efforts
Lecia Bushak
September 22, 2022
9:59 am

Novo Nordisk recently released a new report that outlines its aspirations advancing DE&I internally — as well as in communities facing high rates of diabetes.

Q&A: DeepIntent COO weighs in on media consumption trends
Q&A: DeepIntent COO weighs in on media consumption trends
Jack O'Brien
August 18, 2022
12:32 pm

The organization’s first COO, Amit Chaturvedi, discusses the fractured media landscape and the need for streaming services to “competitively steal” customers.

Q&A: Taye Diggs talks insomnia
Q&A: Taye Diggs talks insomnia
Lecia Bushak
July 13, 2022
11:00 am

Actor Taye Diggs is partnering with Idorsia to raise awareness of sleep’s importance to good physical and mental health.

  • From Our Partners